CLSK Form 4: Officer Reports Share Sale and Large RSU Grants with Multi-Year Vesting
Rhea-AI Filing Summary
Taylor Monnig, CTO and COO of CleanSpark, Inc. (CLSK), filed a Form 4 reporting changes in beneficial ownership. The filing shows a disposition of 129,313 shares of Common Stock on 09/04/2025. It also discloses derivative holdings: employee stock options to buy 15,000 shares at $5.98 (exp. 08/10/2032) and 25,000 shares at $6.00 (exp. 07/06/2033). Multiple restricted stock unit (RSU) awards are reported, including vested or newly acquired RSUs totaling 1,585, -476 (see tables) with specified vesting schedules between 2025 and 2028. The Form is signed by Taylor Monnig on 09/08/2025.
Positive
- Detailed vesting schedules disclosed for RSUs and options through 2028, enabling clear modeling of future share issuance
- Officer retained meaningful long-term equity positions via RSUs and options, aligning compensation with multi-year performance
Negative
- Reported disposition of 129,313 common shares on 09/04/2025, which reduces the reporting person's direct holdings
- Potential future dilution from sizable RSU grants and outstanding options that vest/exercise through 2028
Insights
TL;DR: Insider reported a sizable sale and material equity compensation with multi-year vesting schedules.
The reported disposition of 129,313 common shares is the most immediately material action for investors, as it reduces the reporting persons direct share count. Concurrently, the filing details substantial equity compensation positions: two option grants (15,000 and 25,000 shares) and multiple RSU allocations that vest through 2028. These derivative holdings represent future potential dilution when exercised or vested, but the filing provides explicit vesting timelines and exercise prices, allowing precise modeling of potential share count changes. No forward-looking statements or transaction prices for the disposition are provided.
TL;DR: Transaction shows routine insider compensation and a reported sale; disclosures follow Section 16 reporting norms.
The Form 4 lists the reporting person as an officer (CTO, COO) and properly itemizes both non-derivative and derivative changes. The mix of a reported disposal and multiple RSU grants with staggered vesting is consistent with standard executive compensation practices. The document includes grant dates, exercise prices for options, and detailed vesting schedules, which support governance transparency. There is no indication in the filing of any related-party transactions or exceptions to Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 396,476 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 361,000 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 361,000 | $0.00 | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These Options were granted on August 10, 2022 and vest in equal annual installments over three years. These Options were granted on July 7, 2023 and vest in equal monthly installments over 36 months. These RSUs vest 50% on September 30, 2025 and 50% on September 30, 2026. These RSUs vest in equal quarterly installments on December 3, 2025, February 13, 2026, May 13, 2026, August 13, 2026, December 3, 2026, February 12, 2027, May 13, 2027, August 13, 2027, and December 3, 2027. These RSUs vest in equal annual installments over three years on September 4, 2026, September 4, 2027, and September 4, 2028. These RSUs vest 25% on September 9, 2025; the remaining 75% vests in equal semiannual installments over three years on February 13, 2026, September 4, 2026, February 13, 2027, September 4, 2027, February 13, 2028, and September 4, 2028.
